Follow-up surgical excision is indicated when breast core needle biopsies show atypical lobular hyperplasia or lobular carcinoma in situ: A correlative study of 33 patients with review of the literature

American Journal of Surgical Pathology

Volumn 29, Issue 4, 2005, Pages 534-543

  Elsheikh, Tank M ^a   Silverman, Jan F ^b  

^a BALL MEMORIAL HOSPITAL   (United States)

^b ALLEGHENY GENERAL HOSPITAL   (United States)

Author keywords

Atypical lobular hyperplasia; Lobular carcinoma in situ; Lobular neoplasia; Needle core biopsy

Indexed keywords

ADULT; AGED; BREAST ATYPICAL LOBULAR HYPERPLASIA; BREAST BIOPSY; BREAST CANCER; BREAST CORE NEEDLE BIOPSY; BREAST HYPERPLASIA; BREAST LOBULAR CARCINOMA IN SITU; CANCER RISK; CHEMOPROPHYLAXIS; CLINICAL ARTICLE; FEMALE; FOLLOW UP; HIGH RISK PATIENT; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; MAMMOGRAPHY; NEEDLE BIOPSY; REVIEW; SOFT TISSUE CALCIFICATION; SURGICAL TECHNIQUE;

ADULT; AGED; AGED, 80 AND OVER; BIOPSY, NEEDLE; BREAST; BREAST NEOPLASMS; CARCINOMA IN SITU; CARCINOMA, LOBULAR; FEMALE; FOLLOW-UP STUDIES; HUMANS; HYPERPLASIA; MIDDLE AGED; PRECANCEROUS CONDITIONS; REOPERATION; TREATMENT OUTCOME;

EID: 15744398275     PISSN: 01475185     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.pas.0000152566.78066.d1     Document Type: Review

References (67)

1. Image-detected breast cancer: state of the art diagnosis and treatment. International Breast Cancer Consensus Conference. J Am Coll Surg 2001;193:297-302.
2. Anderson BO, Lawton TJ, Moe RE. Lobular carcinoma in situ and its relationships to ductal carcinoma in situ and invasive lobular carcinoma. In: Challenging Concepts in Breast Cancer Biology. Breast Diseases: A Year Book Quarterly. 2002;13:123-127.
3. A. Arpino G, Allred DC, Mohsin SK, et al. Lobular neoplasia on core-needle biopsy-clinical significance. Cancer 2004;101:242-250.
4. Bassett L, Winchester DP, Caplan RB, et al. Stereotactic core-needle biopsy of the breast: a report of the Joint Task Force of the American College of Radiology, American College of Surgeons, and College of American Pathologists. CA Cancer J Clin. 1997;47:171-190.
5. Bauer VP, Ditkoff BA, Schnabel F, et al. The management of lobular neoplasia identified on percutaneous core breast biopsy. Breast J. 2003; 9:4-9.
6. Berg WA, Mrose HE, Ioffe OB. Atypical lobular hyperplasia or lobular carcinoma in situ at core-needle breast biopsy. Radiology. 2001;218: 503-509.
7. Berx G, Cleton-Jansen AM, Strumane K, et al. B-cadheria is inactivated in a majority of invasive human lobular breast cancers by truncation mutations throughout its extracellular domain. Oncogene. 1996;13: 1919-1925.
8. Bonnett M, Wallis T, Rossmann M, et al. Histopathologic analysis of atypical lesions in image-guided core breast biopsies. Mod Pathol. 2003;16:154-160.
9. Bratthauer GL, Moinfar F, Stamatakos MD, et al. Combined E-cadherin and high molecular weight cytokeratin immunoprofile differentiates lobular, ductal, and hybrid mammary intraepithelial neoplasias. Hum Pathol. 2002;33:620-627.
10. Brenner RJ, Fajardo L, Fisher PR, et al. Percutaneous core biopsy of the breast: effect of operator experience and number of samples on diagnostic accuracy. AJR Am J Roentgenol. 1996;166:341-346.
11. Brown TA, Wall JW, Christensen ED, et al. Atypical hyperplasia in the era of stereotactic core needle biopsy. J Surg Oncol. 1998;67:168-173.
12. Burak WE Jr, Owens KE, Tighe MB, et al. Vacuum-assisted stereotactic breast biopsy: histologic underestimation of malignant lesions. Arch Surg. 2000;135:700-703.
13. Cummings SR, Norton L, Eckert S, et al. Raloxifene reduces the risk of breast cancer and may decrease the risk of endometrial cancer in postmenopausal women: two-year findings from the multiple outcomes of raloxifene evaluation (MORE) trial [Abstract]. Presented at the Program/Proceedings of the American Society of Clinical Oncology, Philadelphia, 1998:2.
14. Dmytrasz K, Tartter PI, Mizrachy H, et al. The significance of atypical lobular hyperplasia at percutaneous breast biopsy. Breast J. 2003;9:10-12.
15. Elvecrog EL, Lechner MC, Nelson MT. Nonpalpable breast lesions: correlation of stereotaxic large-core needle biopsy and surgical biopsy results. Radiology. 1993;188:453-455.
16. Fisher B, Costantino JP, Wickerham DL, et al. Tamoxifen for prevention of breast cancer: report of the National Surgical Adjuvant Breast and Bowel Project P-1 Study. J Natl Cancer Inst. 1998;90: 1371-1388.
17. Fisher ER, Costantino J, Fisher B, et al. Pathologic findings from the National Surgical Adjuvant Breast Project (NSABP) Protocol B-17: five-year observations concerning lobular carcinoma in situ. Cancer. 1996;78:1403-1416.
18. Footc FW, Stewart PW. Lobular carcinoma in situ: a rare form of mammary carcinoma. Am J Pathol. 1941;17:491-499.
19. Foster MC, Helvie MA, Gregory NE, et al. Lobular carcinoma in situ or atypical lobular hyperplasia at core-needle biopsy: is excisional biopsy necessary? Radiology 2004;231:813-819.
20. Frykberg ER, Bland KI. In situ breast carcinoma. Adv Surg. 1993;26:29-72.
21. Gabriel H. The dilemma of lobular carcinoma in situ at percutaneous biopsy: to excise or to monitor. AJR Am J Roentgenol. 1999;173:300-302.
22. Georgian-Smith D, Lawton TJ. Calcifications of lobular carcinoma in situ of the breast: radiologic-pathologic correlation. AJR Am J Roentgenol. 2001;176:1255-1259.
23. Gisvold JJ, Goellner JR, Grant CS, et al. Breast biopsy: a comparative study of stereotaxically guided core and excisional techniques. AJR Am J Roentgenol. 1994;162:815-820.
24. Goldstein NS, Kestin LL, Vicini FA. Clinicopathologic implications of E-cadherin reactivity in patients with lobular carcinoma in situ of the breast. Cancer. 2001;92:738-747.
25. Group EBCTC. Tamoxifen for early breast cancer: an overview of the randomized trials. Lancet. 1998;351:1451-1467.
26. Guenin MA. Is excision of all lobular carcinoma in situ really necessary? Radiology. 2001;219:295-297.
27. Harvey JM, Sterrett GF, Frost FA. Atypical ductal hyperplasia and atypia of uncertain significance in core biopsies from mammographically detected lesions: correlation with excision diagnosis. Pathology. 2002;34:410-416.
28. Homer MJ, Safaii H, Smith TJ, et al. The relationship of mammographic microcalcification to histologic malignancy: radiologic-pathologic correlation. AJR Am J Roentgenol. 1989;153:1187-1189.
29. Ioffe OB, Berg WA, Silverberg SG, et al. Mammographic-histopathologic correlation of large-core needle biopsies of the breast. Mod Pathol. 1998;11:721-727.
30. A. Irfan K, Brem RF. Surgical and mammographic follow-up of papillary lesions and atypical lobular hyperplasia diagnosed with stereotactic vacuum-assisted biopsy. Breast J. 2002;8:230-233.
31. Jackman RJ, Burbank F, Parker SH, et al. Stereotactic breast biopsy of nonpalpable lesions: determinants of ductal carcinoma in situ underestimation rates. Radiology. 2001;218:497-502.
32. Jacobs TW, Connolly JL, Schnitt SJ. Nonmalignant lesions in breast core needle biopsies: to excise or not to excise? Am J Surg Pathol. 2002;26:1095-1110.
33. Jacobs TW, Pliss N, Kouria G, et al. Carcinomas in situ of the breast with indeterminate features: role of E-cadherin staining in categorization. Am J Surg Pathol. 2001;25:229-236.
34. Jordan VC, Glusman JE, Eckert S, et al. Incident primary breast cancers are reduced by raloxifene: integrated data from multicenter, double-blind, randomized trials in 12,000 postmenopausal women [Abstract]. Program/Proceedings of the American Society of Clinical Oncology. Perry MC, ed. Philadelphia: Saunders, 1998:2.
35. Kerner H, Lichtig C. Lobular cancerization: incidence and differential diagnosis with lobular carcinoma in situ of the breast. Histopathology. 1986;10:621-629.
36. Koerner F, Maluf H. Uncommon morphologic patterns of lobular neoplasia. Ann Diagn Pathol. 1999;3:249-259.
37. Lakhani S, Collins N, Sloane J, et al. Loss of heterozygosity in lobular carcinoma in situ of the breast. J Clin Pathol Mol Pathol. 1995;48:M74-M8.
38. Lakhani SR. In-situ lobular neoplasia: time for an awakening. Lancet. 2003;361:96.
39. Lechner MC, Jackman RJ, Brem RF, et al. Labular carcinoma in situ and atypical lobular hyperplasia at percutaneous biopsy with surgical correlation: a multi-institutional study (Abstract). Radiology. 1999;213: 106.
40. Lemanne D, Simon M, Martino S, et al. Breast carcinoma in situ: greater rise in ductal carcinoma in situ vs. lobular carcinoma in situ. Proc Am Soc Clin Oncol. 1991;10:45.
41. Liberman L, Dershaw DD, Rosen PP, et al. Stereotaxic 14-gauge breast biopsy: how many core biopsy specimens are needed? Radiology. 1994;192:793-795.
42. Liberman L, Sama M, Susnik B, et al. Lobular carcinoma in situ at percutaneous breast biopsy: surgical biopsy findings. AJR Am J Roentgenol. 1999;173:291-299.
43. Lishman SC, Lakhani SR. Atypical lobular hyperplasia and lobular carcinoma in situ: surgical and molecular pathology. Histopathology. 1999;35:195-200.
44. Lu YJ, Osin P, Lakhani SR, et al. Comparative genomic hybridization analysis of lobular carcinoma in situ and atypical lobular hyperplasia and potential roles for gains and losses of genetic material in breast neoplasia. Cancer Res. 1998;58:4721-4727.
45. Maluf HM, Swanson PE, Koerner FC. Solid low-grade in situ carcinoma of the breast: role of associated lesions and E-cadherin in differential diagnosis. Am J Surg Pathol. 2001;25:237-244.
46. Middleton LP, Grant S, Stephens T, et al. Lobular carcinoma in situ diagnosed by core needle biopsy: when should it be excised? Mod Pathol. 2003;16:120-129.
47. Murphy WA, DeSchryver-Kecskemeti K. Isolated clustered microcalcifications in the breast: radiologic-pathologic correlation. Radiology. 1978;127:335-341.
48. Nayar R, Zhuang Z, Merino MJ, et al. Loss of heterozygosity on chromosome 11q13 in lobular lesions of the breast using tissue microdissection and polymerase chain reaction. Hum Pathol. 1997;28: 277-282.
49. O'Driscoll D, Britton P, Bobrow L, et al. Lobular carcinoma in situ on core biopsy-what is the clinical significance? Clin Radiol. 2001;56:216-220.
50. Orel SG, Kay N, Reynolds C, et al. B1-RADS categorization as a predictor of malignancy. Radiology. 1999;211:845-850.
51. Pacelli A, Rhodes DJ, Amrami KK. Outcome of atypical lobular hyperplasia and lobular carcinoma in situ diagnosed by core needle biopsy: clinical and surgical follow-up of 30 cases [Meeting Abstract]. Am J Clin Pathol. 2001;116:591.
52. Page DL, Anderson TJ. Diagnostic Histopathology of the Breast. Edinburgh: Churchill Livingstone, 1987.
53. Page DL, Dupont WD, Rogers LW, et al. Atypical hyperplastic lesions of the female breast: a long-term follow-up study. Cancer. 1985;55:2698-2708.
54. Page DL, Schuyler PA, Dupont WD, et al. Atypical lobular hyperplasia as a unilateral predictor of breast cancer risk: a retrospective cohort study. Lancet. 2003;361:125-129.
55. Parker SH, Burbank F, Jackman RJ, et al. Percutaneous large-core breast biopsy: a multi-institutional study. Radiology. 1994;193:359-364.
56. Parker SH, Lovin JD, Jobe WE, et al. Nonpalpable breast lesions: stereotactic automated large-core biopsies. Radiology. 1991;180:403-407.
57. Philpotts LE, Shaheen NA, Jain KS, et al. Uncommon high-risk lesions of the breast diagnosed at stereotactic core-needle biopsy: clinical importance. Radiology 2000;216:831-837.
58. Renshaw AA, Cartagena N, Derhagopian RP, et al. Lobular neoplasia in breast core needle biopsy specimens is not associated with an increased risk of ductal carcinoma in situ or invasive carcinoma. Am J Clin Pathol. 2002;117:797-799.
59. Sapino A, Frigerio A, Peterse JL, et al. Mammographically detected in situ lobular carcinomas of the breast. Virchows Arch. 2000;436:421-430.
60. Schnitt SJ, Morrow M. Lobular carcinoma in situ: current concepts and controversies. Semin Diagn Pathol. 1999;16:209-223.
61. Selim A, Tahan SR. Microscopic localization of calcifications in and around breast carcinoma: a cautionary note for needle core biopsies. Ann Surg. 1998;228:95-98.
62. Shin SJ, Rosen PP. Excisional biopsy should be performed if lobular carcinoma in situ is seen on needle core biopsy. Arch Pathol Lab Med. 2002;126:697-701.
63. Sneige N, Lim SC, Whitman GJ, et al. Atypical ductal hyperplasia diagnosis by directional vacuum-assisted stereotactic biopsy of breast microcalcifications: considerations for surgical excision. Am J Clin Pathol. 2003;119:248-253.
64. Sonnenfeld MR, Frenna TH, Weidner N, et al. Lobular carcinoma in situ: mammographic-pathologic correlation of results of needle-directed biopsy. Radiology. 1991;181:363-367.
65. Tavassoli FA. Pathology of the Breast. Stamford, CT: Appleton & Lange, 1999.
66. Yeh IT, Dimitrov D, Otto P, et al. Pathologic review of atypical hyperplasia identified by image-guided breast needle core biopsy. Correlation with excision specimen. Arch Pathol Lab Med. 2003;127:49-54.
67. Zhang RR, O'Hea BJ, Brebbia JR, et al. Atypical lobular hyperplasia or lobular carcinoma in situa on large core needle biopsy of the breast: is surgical excision necessary? (Abstract). Am J Clin Pathol 2001;116:610.